...
首页> 外文期刊>Toxicology Letters: An International Journal Providing a Forum for Original and Pertinent Contributions in Toxicology Research >DNA alkylation lesions and their repair in human cells: Modification of the comet assay with 3-methyladenine DNA glycosylase (AlkD)
【24h】

DNA alkylation lesions and their repair in human cells: Modification of the comet assay with 3-methyladenine DNA glycosylase (AlkD)

机译:DNA烷基化损伤及其在人类细胞中的修复:用3-甲基腺嘌呤DNA糖基化酶(AlkD)修改彗星试验

获取原文
获取原文并翻译 | 示例
           

摘要

3-Methyladenine DNA glycosylase (AlkD) belongs to a new family of DNA glycosylases; it initiates repair of cytotoxic and promutagenic alkylated bases (its main substrates being 3-methyladenine and 7-methylguanine). The modification of the comet assay (single cell gel electrophoresis) using AlkD enzyme thus allows assessment of specific DNA alkylation lesions. The resulting baseless sugars are alkali-labile, and under the conditions of the alkaline comet assay they appear as DNA strand breaks. The alkylating agent methyl methanesulfonate (MMS) was used to induce alkylation lesions and to optimize conditions for the modified comet assay method with AlkD on human lymphoblastoid (TK6) cells. We also studied cellular and in vitro DNA repair of alkylated bases in DNA in TK6 cells after treatment with MMS. Results from cellular repair indicate that 50% of DNA alkylation is repaired in the first 60. min. The in vitro repair assay shows that while AlkD recognises most alkylation lesions after 60. min, a cell extract from TK6 cells recognises most of the MMS-induced DNA adducts already in the first 15. min of incubation, with maximum detection of lesions after 60. min' incubation. Additionally, we tested the in vitro repair capacity of human lymphocyte extracts from 5 individuals and found them to be able to incise DNA alkylations in the same range as AlkD. The modification of the comet assay with AlkD can be useful for in vitro and in vivo genotoxicity studies to detect alkylation damage and repair and also for human biomonitoring and molecular epidemiology studies.
机译:3-甲基腺嘌呤DNA糖基化酶(AlkD)属于DNA糖基化酶的新家族。它开始修复细胞毒性和促突变的烷基化碱基(其主要底物是3-甲基腺嘌呤和7-甲基鸟嘌呤)。因此,使用AlkD酶对彗星分析(单细胞凝胶电泳)进行的修改允许评估特定的DNA烷基化损伤。所得的无碱糖是碱不稳定的,并且在碱彗星试验的条件下,它们以DNA链断裂的形式出现。烷基化剂甲磺酸甲酯(MMS)用于诱导烷基化损伤并优化AlkD对人淋巴母细胞(TK6)细胞的改良彗星测定方法的条件。我们还研究了MMS处理后TK6细胞中DNA烷基化碱基的细胞和体外DNA修复。细胞修复的结果表明,在最初的60分钟内修复了50%的DNA烷基化。体外修复测定法显示,虽然AlkD在60分钟后识别出大多数烷基化损伤,但从TK6细胞提取的细胞提取物在孵育的前15分钟中已经识别出大多数MMS诱导的DNA加合物,在60分钟后最大程度地检测到损伤分钟的孵化。此外,我们测试了来自5个个体的人类淋巴细胞提取物的体外修复能力,发现它们能够在与AlkD相同的范围内切割DNA烷基化。用AlkD修改彗星实验可用于体外和体内遗传毒性研究,以检测烷基化损伤和修复,还可用于人类生物监测和分子流行病学研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号